Fri. Dec 2nd, 2022
Lupin Q2 Preview: Adjusted profit may decline sharply on subdued revenue, operating performance Guidance for launches and traction in the US in the second half of FY21 and update on albuterol market share after its launch in the American market would be key things to watch out for.